← Leaderboards
John R Dedman
University Of Cincinnati
$2,372,932
Attributed
$2,372,932
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,372,932 · 2
By mechanism
R01$2,372,932 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Katherine Anne Burns$4,616,689
- Joseph Cuschieri$2,006,723
- Evangelia G Kranias$18,880,856
- Per-Olof J Hasselgren$6,129,994
- Winston W Kao$15,185,269
Others in their field
Top investigators on “Genetically Modified Animals”
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$42,971,897
- C Ronald Kahn · Joslin Diabetes Center$28,941,790
- Edward E Partridge · University Of Alabama At Birmingham$26,712,465
- Ronald B Corley · Boston University Medical Campus$26,592,975
- John T Potts · Massachusetts General Hospital$25,176,515
- Reisa A. Sperling · Banner Health$24,903,674
Research focus
Genetically Modified AnimalsLaboratory MousePeptide LibraryCalmodulinCalmodulin Dependent Protein KinaseCell Growth RegulationCell LineEnzyme ActivityEnzyme InhibitorsEnzyme MechanismGene ExpressionGene MutationVoltage /Patch ClampCalcineurinCalcium FluxGenetic Promoter ElementGrowth InhibitorsLung AlveolusOligopeptidesOxidative StressProtein SequenceRespiratory EpitheliumTransfectionNonhuman Therapy Evaluation
Grant awards (12)
DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS$321,344
R01 · FY2003 · DK
TREATMENT STRATEGIES FOR THE ANTI PHOSPHOLIPID SYNDROME$255,931
R01 · FY2003 · HL
DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS$48,638
R01 · FY2003 · DK
DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS$313,413
R01 · FY2002 · DK
TREATMENT STRATEGIES FOR THE ANTI PHOSPHOLIPID SYNDROME$254,021
R01 · FY2002 · HL
DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS$30,529
R01 · FY2002 · DK
DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS$305,711
R01 · FY2001 · DK
TREATMENT STRATEGIES FOR THE ANTI PHOSPHOLIPID SYNDROME$246,852
R01 · FY2001 · HL
DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS$39,522
R01 · FY2001 · DK
DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS$298,156
R01 · FY2000 · DK
TREATMENT STRATEGIES FOR THE ANTI PHOSPHOLIPID SYNDROME$220,445
R01 · FY2000 · HL
DESIGN AND TRANSGENIC ANALYSIS OF CELLULAR INHIBITORS$38,370
R01 · FY2000 · DK